UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection

Pharmaceutics, 2021-07, Vol.13 (7), p.1077

2021

Link zum Volltext

Verfügbarkeit prüfen

Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols

Pharmaceutics, 2022-09, Vol.14 (9), p.1870

2022

Link zum Volltext

Verfügbarkeit prüfen

PNA6, a Lactosyl Analogue of Angiotensin-(1-7), Reverses Pain Induced in Murine Models of Inflammation, Chemotherapy-Induced Peripheral Neuropathy, and Metastatic Bone Disease

International journal of molecular sciences, 2023-10, Vol.24 (19), p.15007

2023

Link zum Volltext

Verfügbarkeit prüfen

Neurofilament light: a possible prognostic biomarker for treatment of vascular contributions to cognitive impairment and dementia

Journal of neuroinflammation, 2021-10, Vol.18 (1), p.236-236, Article 236

2021

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and In Vitro Characterization of Glycopeptide Drug Candidates Related to PACAP1–23

Molecules (Basel, Switzerland), 2021-08, Vol.26 (16), p.4932

2021

Link zum Volltext

Verfügbarkeit prüfen

Organic Solution Advanced Spray-Dried Microparticulate/Nanoparticulate Dry Powders of Lactomorphin for Respiratory Delivery: Physicochemical Characterization, In Vitro Aerosol Dispersion, and Cellular Studies

Pharmaceutics, 2020-12, Vol.13 (1), p.26

2020

Link zum Volltext

Verfügbarkeit prüfen

Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release

Pharmaceutics, 2022-03, Vol.14 (3), p.587

2022

Link zum Volltext

Verfügbarkeit prüfen

A PM-IRRAS Investigation of Monorhamnolipid Orientation at the Air–Water Interface

Langmuir, 2013-04, Vol.29 (14), p.4441-4450

2013

Link zum Volltext

Verfügbarkeit prüfen

The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia

International journal of molecular sciences, 2020-12, Vol.22 (1), p.20

2020

Link zum Volltext

Verfügbarkeit prüfen

In silico Docking Studies of Fingolimod and S1P1 Agonists

Frontiers in pharmacology, 2020-03, Vol.11, p.247-247

2020

Link zum Volltext

Verfügbarkeit prüfen

Synthesis, Physicochemical Characterization, In Vitro 2D/3D Human Cell Culture, and In Vitro Aerosol Dispersion Performance of Advanced Spray Dried and Co-Spray Dried Angiotensin (1-7) Peptide and PNA5 with Trehalose as Microparticles/Nanoparticles for Targeted Respiratory Delivery as Dry Powder Inhalers

Pharmaceutics, 2021-08, Vol.13 (8), p.1278

2021

Link zum Volltext

Verfügbarkeit prüfen

Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model

BMC research notes, 2020-03, Vol.13 (1), p.149-6, Article 149

2020

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin-(1-7) Peptide Hormone Reduces Inflammation and Pathogen Burden during Mycoplasma pneumoniae Infection in Mice

Pharmaceutics, 2021-10, Vol.13 (10), p.1614

2021

Link zum Volltext

Verfügbarkeit prüfen

Glycopeptide drugs: A pharmacological dimension between “Small Molecules” and “Biologics”

Peptides (New York, N.Y. : 1980), 2020-09, Vol.131, p.170369-170369, Article 170369

2020

Link zum Volltext

Verfügbarkeit prüfen

Sphingosine-1-phosphate receptor-independent lung endothelial cell barrier disruption induced by FTY720 regioisomers

Pulmonary circulation, 2020-01, Vol.10 (1), p.1-10

2020

Link zum Volltext

Verfügbarkeit prüfen

Strain Differences in the Delta Opioid Receptor Agonist Properties of the Multifunctional Opioid Glycopeptide MMP2200

The FASEB journal, 2021-05, Vol.35 (S1), p.n/a, Article fasebj.2021.35.S1.04174

2021

Link zum Volltext

Verfügbarkeit prüfen

Spray-Dried Inhalable Powder Formulations of Therapeutic Proteins and Peptides

AAPS PharmSciTech, 2021-06, Vol.22 (5), p.185-185, Article 185

2021

Link zum Volltext

Verfügbarkeit prüfen

New prospects for glycopeptide based analgesia: glycoside-induced penetration of the blood-brain barrier

Current drug delivery, 2005-01, Vol.2 (1), p.59

2005

Link zum Volltext

Verfügbarkeit prüfen

Abstract 11926: Angiotensin-(1-7)/mas Receptor Agonist Protects Hippocampus Neurons In Mouse Model Of Vascular Dementia

Circulation (New York, N.Y.), 2021-11, Vol.144 (Suppl_1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides

The Journal of pharmacology and experimental therapeutics, 2004-10, Vol.311 (1), p.290

2004

Link zum Volltext

Verfügbarkeit prüfen

PACAP glycosides promote cell outgrowth in vitro and reduce infarct size after stroke in a preclinical model

Neuroscience letters, 2024-07, Vol.836, p.137883, Article 137883

2024

Link zum Volltext

Verfügbarkeit prüfen

Design and synthesis of oxytocin glycosides for the treatment of pain and substance use disorder

Methods in enzymology, 2024-01, Vol.698, p.343

2024

Link zum Volltext

Verfügbarkeit prüfen

Characterization of Delta Opioid Receptor Activity of MMP2200, a Mixed Efficacy Mu and Delta Opioid Receptor Agonist

The FASEB journal, 2020-04, Vol.34 (S1), p.1-1

2020

Link zum Volltext

Verfügbarkeit prüfen

A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction

The Journal of pharmacology and experimental therapeutics, 2019-04, Vol.369 (1), p.9

2019

Link zum Volltext

Verfügbarkeit prüfen

An update on sphingosine-1-phosphate receptor 1 modulators

Bioorganic & medicinal chemistry letters, 2018-12, Vol.28 (23-24), p.3585-3591

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(121)

Publikationsform

Sprache

Englisch
(130)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection

Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols

PNA6, a Lactosyl Analogue of Angiotensin-(1-7), Reverses Pain Induced in Murine Models of Inflammation, Chemotherapy-Induced Peripheral Neuropathy, and Metastatic Bone Disease

Neurofilament light: a possible prognostic biomarker for treatment of vascular contributions to cognitive impairment and dementia

Synthesis and In Vitro Characterization of Glycopeptide Drug Candidates Related to PACAP1–23

Organic Solution Advanced Spray-Dried Microparticulate/Nanoparticulate Dry Powders of Lactomorphin for Respiratory Delivery: Physicochemical Characterization, In Vitro Aerosol Dispersion, and Cellular Studies

Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release

A PM-IRRAS Investigation of Monorhamnolipid Orientation at the Air–Water Interface

The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia

In silico Docking Studies of Fingolimod and S1P1 Agonists

Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model

Angiotensin-(1-7) Peptide Hormone Reduces Inflammation and Pathogen Burden during Mycoplasma pneumoniae Infection in Mice

Glycopeptide drugs: A pharmacological dimension between “Small Molecules” and “Biologics”

Sphingosine-1-phosphate receptor-independent lung endothelial cell barrier disruption induced by FTY720 regioisomers

Strain Differences in the Delta Opioid Receptor Agonist Properties of the Multifunctional Opioid Glycopeptide MMP2200

Spray-Dried Inhalable Powder Formulations of Therapeutic Proteins and Peptides

New prospects for glycopeptide based analgesia: glycoside-induced penetration of the blood-brain barrier

Abstract 11926: Angiotensin-(1-7)/mas Receptor Agonist Protects Hippocampus Neurons In Mouse Model Of Vascular Dementia

Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides

PACAP glycosides promote cell outgrowth in vitro and reduce infarct size after stroke in a preclinical model

Design and synthesis of oxytocin glycosides for the treatment of pain and substance use disorder

Characterization of Delta Opioid Receptor Activity of MMP2200, a Mixed Efficacy Mu and Delta Opioid Receptor Agonist

A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction

An update on sphingosine-1-phosphate receptor 1 modulators

Suchergebnisse filtern